hydroxyindoleacetic acid has been researched along with Alcohol Abuse in 123 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Excerpt | Relevance | Reference |
---|---|---|
" For example, hypothesized serotonergic deficits in alcoholism, endorphin deficits in opioid dependence, and dopamine depletion in cocaine dependence all might predispose to depression." | 4.78 | Hypothesized neurochemical models for psychiatric syndromes in alcohol and drug dependence. ( Extein, IL; Gold, MS, 1993) |
"Among treatment-seeking alcoholics, early age at onset is generally associated with a more severe course of alcoholism and lower cerebrospinal fluid 5-hydroxyindoleacetic acid concentration." | 3.69 | Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics. ( Brown, GL; Eckardt, MJ; Fils-Aime, ML; George, DT; Linnoila, M; Mefford, I, 1996) |
"Among all offenders, low cerebrospinal fluid (CSF) 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) concentrations were associated with a family history positive for paternal alcoholism with violence." | 3.69 | A prospective follow-up study of alcoholic violent offenders and fire setters. ( Eggert, M; Linnoila, M; Rawlings, R; Virkkunen, M, 1996) |
" There were significant, negative correlations between interview-derived lifetime aggression scores and cerebrospinal fluid concentrations of both the serotonin metabolite 5-hydroxyindoleacetic acid and the dopamine metabolite homovanillic acid." | 3.68 | Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls. ( Adinoff, B; Goldman, D; Lamparski, D; Limson, R; Linnoila, M; Ravitz, B; Roy, A, 1991) |
"We review cerebrospinal fluid (CSF) studies suggesting on association between low CSF levels of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAAA) and suicidal and impulsive behaviour and alcoholism." | 3.67 | Reduced central serotonin turnover in a subgroup of alcoholics? ( Linnoila, M; Roy, A; Virkkunen, M, 1987) |
" Recidivists who committed a new violent offense or arson had significantly lower cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid concentrations and blood glucose nadirs after oral glucose challenge than did nonrecidivists." | 3.67 | Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters. A follow-up study. ( Bartko, J; De Jong, J; Goodwin, FK; Linnoila, M; Virkkunen, M, 1989) |
"5-Hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) were measured in the spinal fluid of 45 women hospitalized in a psychiatric department for major depression (14 cases), schizophrenia (18 cases) and alcohol dependence (13 cases)." | 3.66 | Relationship between cerebrospinal fluid amine metabolites, neuroendocrine findings and personality dimensions (Marke-Nyman scale factors) in psychiatric patients. ( Arató, M; Banki, CM, 1983) |
"5-Hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) were measured in the lumbar cerebrospinal fluid of 57 drug-free female patients with DSM-III diagnoses of major unipolar or bipolar depression (n = 14), schizophrenic disorder (n = 18), alcohol dependence (n = 13) and a group of other disorders (n = 12)." | 3.66 | Amine metabolites and neuroendocrine responses related to depression and suicide. ( Arató, M; Banki, CM, 1983) |
"Alcohol addiction is associated with alterations of central nervous dopaminergic and serotonergic functions." | 1.36 | Serotonergic function, substance craving, and psychopathology in detoxified alcohol-addicted males undergoing tryptophan depletion. ( Bandelow, B; Engel, K; Falkai, P; Havemann-Reinecke, U; Herchenhein, T; Kirchhainer, J; Malchow, B; Wedekind, D, 2010) |
"Alcoholism is a complex disorder involving, among others, the serotoninergic (5-HT) system, mainly regulated by 5-HT(1A) autoreceptors in the dorsal raphe nucleus." | 1.35 | Chronic voluntary ethanol intake hypersensitizes 5-HT(1A) autoreceptors in C57BL/6J mice. ( Chouchana, L; Hamon, M; Hanoun, N; Kelaï, S; Lanfumey, L; Renoir, T; Saurini, F, 2008) |
"Perpetrators with alcohol dependence (DV-ALC) (n=13), perpetrators without alcohol dependence (DV-NALC) (n=10) and healthy comparison subjects (HCS) (n=20) were clinically assessed using the Spielberger Trait Anxiety, Brown-Goodwin Aggression Scale, Buss Durkee Hostility Inventory and Straus Conflict Tactics." | 1.31 | Serotonin, testosterone and alcohol in the etiology of domestic violence. ( Emmela, D; George, DT; Phillips, MJ; Ragan, PW; Rawlings, RR; Shoaf, SE; Umhau, JC, 2001) |
"Alcoholic, impulsive offenders with antisocial personality disorder had low mean cerebrospinal fluid (CSF) 5-hydroxyindoleacetic acid (5-HIAA) and corticotropin levels and high mean CSF testosterone concentrations." | 1.29 | CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. ( Bissette, G; Guidotti, A; Kalogeras, K; Karonen, SL; Linnoila, M; Nemeroff, C; Poland, RE; Rawlings, R; Tokola, R; Virkkunen, M, 1994) |
"Plasma 5-HIAA in patients with delirium tremens showed significantly higher levels during the abstention period, possibly suggesting peculiarity in their serotonergic metabolism." | 1.29 | Circadian variation in plasma 5-hydroxyindoleacetic acid level during and after alcohol withdrawal: phase advances in alcoholic patients compared with normal subjects. ( Miyasato, K; Ohara, K; Sano, H; Suzuki, Y; Tamefusa, K; Yazaki, R; Yokoyama, T, 1993) |
" Dose-response curves for DA and 5-HT release indicated no marked difference in the sensitivity to ethanol between the lines." | 1.28 | Ethanol enhances the release of dopamine and serotonin in the nucleus accumbens of HAD and LAD lines of rats. ( Li, TK; Lumeng, L; McBride, WJ; Yoshimoto, K, 1992) |
"Studies have also linked alcohol abuse with aggression and criminality." | 1.27 | Serotonergic activity and disinhibitory psychopathy in alcoholism. ( Moss, HB, 1987) |
"The disulfiram treatment induced elevated (P less than 0." | 1.26 | Concentration of serotonin metabolites in the cerebrospinal fluid from alcoholics before and during disulfiram therapy. ( Beck, O; Borg, S; Holmstedt, B; Kvande, H; Shröder, R, 1980) |
"Severity of withdrawal symptoms assessed on a rating scale in 14 patients with 4 days or less of abstinence correlated marginally with HVA but not with 5-HIAA." | 1.26 | Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. ( Banki, CM, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 58 (47.15) | 18.7374 |
1990's | 49 (39.84) | 18.2507 |
2000's | 13 (10.57) | 29.6817 |
2010's | 3 (2.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kelaï, S | 1 |
Renoir, T | 1 |
Chouchana, L | 1 |
Saurini, F | 1 |
Hanoun, N | 1 |
Hamon, M | 1 |
Lanfumey, L | 1 |
Ward, RJ | 1 |
Colivicchi, MA | 1 |
Allen, R | 1 |
Schol, F | 1 |
Lallemand, F | 1 |
de Witte, P | 1 |
Ballini, C | 1 |
Corte, LD | 1 |
Dexter, D | 1 |
Wargelius, HL | 1 |
Fahlke, C | 1 |
Suomi, SJ | 4 |
Oreland, L | 3 |
Higley, JD | 6 |
Asellus, P | 1 |
Nordström, P | 1 |
Jokinen, J | 1 |
Wedekind, D | 1 |
Herchenhein, T | 1 |
Kirchhainer, J | 1 |
Bandelow, B | 1 |
Falkai, P | 1 |
Engel, K | 1 |
Malchow, B | 1 |
Havemann-Reinecke, U | 1 |
Heinz, A | 2 |
Jones, DW | 2 |
Bissette, G | 4 |
Hommer, D | 3 |
Ragan, P | 1 |
Knable, M | 1 |
Wellek, S | 1 |
Linnoila, M | 36 |
Weinberger, DR | 2 |
Helander, A | 7 |
Eriksson, CJ | 1 |
Sher, L | 3 |
Oquendo, MA | 2 |
Li, S | 1 |
Huang, YY | 2 |
Grunebaum, MF | 2 |
Burke, AK | 2 |
Malone, KM | 1 |
Mann, JJ | 2 |
MURPHY, GE | 1 |
GUZE, SB | 1 |
KING, LJ | 1 |
VOJTECHOVSKY, M | 1 |
RYSANEK, K | 1 |
VITEK, V | 1 |
Ducci, F | 1 |
Newman, TK | 1 |
Funt, S | 1 |
Brown, GL | 4 |
Virkkunen, M | 21 |
Goldman, D | 8 |
Rissanen, A | 1 |
Naukkarinen, H | 1 |
Franssila-Kallunki, A | 1 |
Tiihonen, J | 1 |
Stenbacka, M | 1 |
Beck, O | 9 |
Leifman, A | 1 |
Romelsjö, A | 1 |
Quintanilla, ME | 1 |
Bustamante, D | 1 |
Tampier, L | 1 |
Israel, Y | 1 |
Herrera-Marschitz, M | 1 |
Rainio, J | 1 |
De Giorgio, F | 1 |
Bortolotti, F | 1 |
Tagliaro, F | 1 |
Zarcone, VP | 1 |
Schreier, L | 2 |
Mitchell, G | 1 |
Orenberg, E | 2 |
Barchas, J | 2 |
Mena, MA | 2 |
Herrera, E | 2 |
Carlsson, A | 1 |
Adolfsson, R | 1 |
Aquilonius, SM | 1 |
Gottfries, CG | 1 |
Svennerholm, L | 1 |
Winblad, B | 2 |
Fujimoto, A | 1 |
Rosenthal, NE | 1 |
Davenport, Y | 1 |
Cowdry, RW | 1 |
Webster, MH | 1 |
Goodwin, FK | 3 |
Borg, S | 7 |
Holmstedt, B | 1 |
Kvande, H | 1 |
Shröder, R | 1 |
Banki, CM | 8 |
Molnár, G | 2 |
Bánki, MC | 1 |
Murphy, JM | 4 |
McBride, WJ | 5 |
Lumeng, L | 5 |
Li, TK | 5 |
Garvey, MJ | 1 |
Tollefson, G | 1 |
van Praag, HM | 1 |
Arató, M | 4 |
Papp, Z | 2 |
Kurcz, M | 1 |
Sjöquist, B | 1 |
Perdahl, E | 1 |
Martin, PR | 1 |
Ebert, MH | 2 |
Gordon, EK | 1 |
Kopin, IJ | 1 |
Martín del Río, R | 1 |
Edman, G | 1 |
Fyrö, B | 1 |
Oxenstierna, G | 1 |
Sedvall, G | 1 |
Lappalainen, J | 2 |
Dean, M | 2 |
Charbonneau, L | 1 |
Extein, IL | 1 |
Gold, MS | 1 |
George, T | 2 |
Higley, D | 1 |
Kallio, E | 1 |
Rawlings, R | 7 |
Tokola, R | 4 |
Poland, RE | 2 |
Guidotti, A | 2 |
Nemeroff, C | 2 |
Kalogeras, K | 2 |
Karonen, SL | 2 |
Nielsen, DA | 2 |
Hartleb, J | 1 |
Eue, S | 1 |
Kemper, A | 1 |
Eckardt, M | 1 |
Nielsen, D | 1 |
Sano, H | 2 |
Suzuki, Y | 2 |
Ohara, K | 4 |
Miyasato, K | 2 |
Yokoyama, T | 2 |
Geracioti, TD | 1 |
Loosen, PT | 1 |
Ekhator, NN | 1 |
Burns, D | 1 |
Nicholson, WE | 1 |
Orth, DN | 1 |
Tipton, KF | 1 |
Harrington, MC | 1 |
Kennedy, NP | 1 |
Bonner, AB | 1 |
Brien, S | 1 |
Preedy, VR | 1 |
Yazaki, R | 1 |
Tamefusa, K | 1 |
Carlsson, AV | 1 |
Hiltunen, AJ | 2 |
Stibler, H | 1 |
Jones, AW | 1 |
Fils-Aime, ML | 1 |
Eckardt, MJ | 2 |
George, DT | 6 |
Mefford, I | 1 |
Eggert, M | 1 |
Carlsson, S | 1 |
Koechling, UM | 1 |
Voltaire-Carlsson, A | 1 |
Faraj, BA | 1 |
Olkowski, ZL | 1 |
Jackson, RT | 1 |
Gorey, JG | 1 |
Saunders, RC | 1 |
Zajicek, K | 1 |
Lesch, KP | 1 |
Hibbeln, JR | 1 |
Umhau, JC | 2 |
Salem, N | 1 |
Spies, CD | 1 |
Herpell, J | 1 |
Müller, C | 1 |
Pragst, F | 1 |
Phillips, MJ | 2 |
Shoaf, SE | 3 |
Williams, WA | 1 |
Wallgren, H | 1 |
Kosunen, AL | 1 |
Ahtee, L | 3 |
Petrakis, IL | 1 |
Trevisan, L | 1 |
D'Souza, C | 1 |
Gil, R | 1 |
Krasnicki, S | 1 |
Webb, E | 1 |
Heninger, G | 1 |
Cooney, N | 1 |
Krystal, JH | 1 |
Long, JC | 1 |
Ozaki, N | 1 |
Emmela, D | 1 |
Ragan, PW | 1 |
Rawlings, RR | 1 |
Tabakoff, B | 2 |
Hoffman, P | 1 |
Moses, F | 1 |
Zarcone, V | 1 |
Benson, K | 1 |
Kato, N | 2 |
Takahashi, S | 2 |
Tani, N | 2 |
Iwase, N | 1 |
Odani, K | 1 |
Terenius, L | 1 |
Wahlström, A | 1 |
Agren, H | 1 |
Ballenger, JC | 1 |
Major, LF | 1 |
Hoffman, PL | 1 |
Akhter, MI | 1 |
Clark, PM | 1 |
Kricka, LJ | 1 |
Nicholson, G | 1 |
Vojnik, M | 1 |
Bo, P | 1 |
Mazzella, GL | 1 |
Mola, M | 1 |
Cattaneo, MR | 1 |
Massarini, M | 1 |
Bolos, AM | 1 |
Yoshimoto, K | 1 |
Whelan, G | 1 |
Linnoila, VM | 1 |
Roy, A | 10 |
Lamparski, D | 2 |
De Jong, J | 4 |
Adinoff, B | 5 |
Ravitz, B | 4 |
Nutt, D | 1 |
Hallman, J | 1 |
von Knorring, AL | 1 |
von Knorring, L | 1 |
Nutt, DJ | 1 |
Berrettini, W | 1 |
Mefford, IN | 1 |
Costa, E | 1 |
Nemeroff, CB | 1 |
DeJong, J | 2 |
Limson, R | 1 |
Wahlström, G | 1 |
Magnusson, O | 1 |
Nordberg, A | 1 |
Stenström, A | 1 |
Tiger, G | 1 |
Akker, LV | 1 |
Gatto, GJ | 1 |
Levy, AD | 1 |
Hendin, H | 1 |
Degrell, I | 1 |
Pék, G | 1 |
Nagy, D | 1 |
Nagy, E | 1 |
Hoyer, S | 1 |
Guthrie, S | 1 |
Moss, HB | 1 |
Bartko, J | 1 |
Badawy, AA | 1 |
Morgan, CJ | 1 |
Lane, J | 1 |
Dhaliwal, K | 1 |
Bradley, DM | 1 |
Lidberg, L | 1 |
Tuck, JR | 1 |
Asberg, M | 1 |
Scalia-Tomba, GP | 1 |
Bertilsson, L | 1 |
Ashcroft, GW | 1 |
Crawford, TB | 1 |
Eccleston, D | 1 |
Sharman, DF | 1 |
MacDougall, EJ | 1 |
Stanton, JB | 1 |
Binns, JK | 1 |
Barnardo, DE | 1 |
Summerskill, WH | 1 |
Strong, CG | 1 |
Baldus, WP | 1 |
Yamane, H | 1 |
Kondo, H | 1 |
Eriksson, K | 2 |
Payne, IR | 1 |
Lu, GH | 1 |
Meyer, K | 1 |
Skugarevskaia, EI | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Double-Blind, Placebo-Controlled Study of Brexpiprazole in the Treatment of Borderline Personality Disorder.[NCT03418675] | Phase 2 | 80 participants (Actual) | Interventional | 2018-11-26 | Completed | ||
The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study: A Double Blind, Placebo-Controlled Trial of Omega-3 Fatty Acid Supplementation Among Military Veterans[NCT01901887] | Phase 1 | 125 participants (Actual) | Interventional | 2014-03-01 | Terminated (stopped due to low recruitment) | ||
Ranger Resilience and Improved Performance on Phospholipid Bound Omega-3's[NCT02908932] | 555 participants (Actual) | Interventional | 2016-08-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
A clinician-administered assessment of anxiety that will be assessed at all study visits (Visit 1-Visit 8). Changes in scores from baseline to final visit will be assessed. Higher scores (up to 56) indicate higher levels of anxiety, with 0 being no symptoms of anxiety. (NCT03418675)
Timeframe: assessed at Visits 1 to 8, change in scores from Visit 1 to Visit 8 (baseline to Week 12) is reported
Intervention | change in score on a scale (Mean) |
---|---|
Placebo | -2.41 |
Rexulti | -4.88 |
A clinician-administered assessment of depression that will be assessed at all study visits (Visits 1-8). Higher total scores indicate higher levels of depression (up to 52), while a score of 0 would indicate no depressive symptoms. (NCT03418675)
Timeframe: Assessed at Visits 1 to 8, change in scores from Visit 1 to Visit 8 (baseline to week 12) is reported
Intervention | change in score on a scale (Mean) |
---|---|
Placebo | -2.09 |
Rexulti | -3.81 |
A self-report assessment of impulsivity that will be assessed at baseline and visit 8. The BIS is composed of 30 items describing common impulsive or non-impulsive (for reverse scored items) behaviors and preferences. Items are scored on a 4-point scale: (Rarely/Never = 1, Occasionally = 2, Often = 3, Almost Always/Always = 4). These scores are summed to produce an overall impulsivity score ranging from 30 (not impulsive) to 120 (extremely impulsive). (NCT03418675)
Timeframe: Baseline (Visit 1), Week 12 (Visit 8)
Intervention | score on a scale (Mean) | |
---|---|---|
Visit 1 | Visit 8 | |
Placebo | 76.53 | 68.13 |
Rexulti | 72.27 | 70.5 |
A self rated scale used to measure severity and change. The first 12 items of the scale are on a scale from 1-5, with 5 meaning that the item caused extreme distress, severe difficulties in relationships, and/or kept them from getting things done. The lowest rating (1) means it caused little or no problems. Items 13-15 (positive behaviors) are rated according to frequency. Completed at every visit. (NCT03418675)
Timeframe: Assessed at Visits 1 to 8, change in scores from Visit 1 to Visit 8 (baseline to week 12) is reported
Intervention | score on a scale (Mean) | |
---|---|---|
Visit 1 | Visit 8 | |
Placebo | 40.90 | 29.15 |
Rexulti | 40.54 | 23.15 |
"A self-report scale measuring suicidality. Subjects will complete the scale at all visits. Subjects are asked about suicidal thoughts. If answers are no, rater can proceed to suicidal behavior section where subject is asked about any non-suicidal self injurious behavior. If yes, subject is asked about intensity of ideations. In the event of serious threat to themselves, the subject will be escorted to the emergency room. Total score indicates severity of suicidal ideation and behavior, with lower scores representing lower levels of suicidality and higher scores representing higher levels of suicidality. A score of 0 would reflect no suicidality present, whereas a maximum score of 5 would reflect active suicidal ideation with intent to act." (NCT03418675)
Timeframe: Baseline (Visit 1), Week 12 (Visit 8)
Intervention | score on a scale (Mean) | |
---|---|---|
Visit 1 | Visit 8 | |
Placebo | 1.15 | 0.23 |
Rexulti | 0.73 | 0.08 |
A short-structured interview that assesses comorbid psychiatric disorders according to the DSM 5 criteria. This assessment will be done during the baseline visit. (NCT03418675)
Timeframe: Baseline (Week 1)
Intervention | Participants (Count of Participants) | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Depressive Episode (Current) | Major Depressive Episode (Past) | Manic Episode (Current) | Manic Episode (Past) | Hypomanic Episode (Current) | Bipolar I Disorder (Current) | Bipolar I Disorder (Past) | Bipolar II Disorder (Current) | Bipolar II Disorder (Past) | Panic Disorder (Current) | Panic Disorder (Lifetime) | Agoraphobia (Current) | Social Anxiety Disorder (Current) | Obsessive Compulsive Disorder (Current) | Post Traumatic Stress Disorder (Current) | Alcohol Use Disorder (Past 12 months) | Substance Use Disorder (Past 12 months) | Any Psychotic Disorder (Current) | Any Psychotic Disorder (Lifetime) | Major Depressive Disorder with Psychotic Features (Current) | Major Depressive Disorder with Psychotic Features (Past) | Anorexia Nervosa (current) | Bulimia Nervosa (Current) | Binge Eating Disorder (Current) | Generalized Anxiety Disorder (Current) | Antisocial Personality Disorder (Lifetime) | ADHD Combined Type (Current) | ADHD Inattentive Type (Current) | ADHD Hyperactive Type (Current) | Tourette's Syndrome (Lifetime) | Persistent Motor Tic Disorder (Lifetime) | Provisional Vocal Tic Disorder (Lifetime) | Provisional Tic Disorder (Lifetime) | Specific Phobia | Body Dysmorphic Disorder (Current) | |
Placebo | 16 | 12 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 6 | 11 | 7 | 6 | 3 | 9 | 13 | 11 | 0 | 0 | 0 | 0 | 0 | 4 | 2 | 10 | 8 | 2 | 0 | 1 | 0 | 1 | 0 | 0 | 4 | 3 |
Rexulti | 18 | 18 | 2 | 3 | 0 | 0 | 0 | 0 | 1 | 6 | 10 | 9 | 9 | 3 | 12 | 8 | 8 | 0 | 1 | 0 | 0 | 1 | 4 | 4 | 15 | 4 | 4 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 2 |
A self-report assessment of patient perceived quality of life that will be assessed at baseline and visit 8. Higher scores indicate a higher quality of life, whereas lower scores indicate a lower quality of life. Participants are asked to rate the importance of each domain on a 3-point scale ranging from 1=not important to 3=very important, and to rate how satisfied they are with that domain on a 6-point scale, ranging from -3=very dissatisfied to +3=very satisfied. In scoring, importance ratings are multiplied by satisfaction ratings to produce weighted satisfaction scores for each of the 16 domains. Weighted satisfaction scores are summed and divided by the number of domains that were rated as important or very important to produce a raw score, which is then converted to a t-score, which provides a proxy measurement for perceived quality of life. T-scores range from very low perceived quality of life (0-36) to high perceived quality of life (58-77). (NCT03418675)
Timeframe: Baseline (Week 1), Week 12 (Visit 8)
Intervention | score on a scale (Mean) | |
---|---|---|
Visit 1 | Visit 8 | |
Placebo | 28.89 | 30.75 |
Rexulti | 28.70 | 35.71 |
A self-report scale assessing Borderline Personality severity that will be assessed at all visits.This scale is assessing severity and change in BPD symptoms. This is a 9-item scale measuring severity of different aspects of Borderline Personality Disorder, with each item rated on a 0-4 scale, 0=no symptoms, 4=severe symptoms. Total scores range from 0-36. (NCT03418675)
Timeframe: Baseline (Visit 1), Week 1 (Visit 2), Week 2 (Visit 3), Week 4 (Visit 4), Week 6 (Visit 5), Week 8 (Visit 6), Week 10 (Visit 7), Week 12 (Visit 8)
Intervention | score on a scale (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | Visit 6 | Visit 7 | Visit 8 | |
Placebo | 18.2 | 12.8 | 10.7 | 10.7 | 9.7 | 9.6 | 8.7 | 9.3 |
Rexulti | 17.6 | 10.9 | 7.9 | 8.0 | 7.0 | 6.6 | 6.0 | 5.8 |
Subjects will complete the SDS at all visits. The change in scores from baseline to study completion will be assessed. The scale itself assesses the level of disability from borderline personality disorder (or target disorder) with higher scores indicating a more debilitating disorder. Scores range from 0-30. (NCT03418675)
Timeframe: Baseline (Visit 1), Week 1 (Visit 2), Week 2 (Visit 3), Week 4 (Visit 4), Week 6 (Visit 5), Week 8 (Visit 6), Week 10 (Visit 7), Week 12 (Visit 8)
Intervention | score on a scale (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | Visit 6 | Visit 7 | Visit 8 | |
Placebo | 17.3 | 13.3 | 11.5 | 12.4 | 11.7 | 11.2 | 12.0 | 12.7 |
Rexulti | 15.8 | 10.7 | 7.8 | 7.8 | 7.0 | 7.9 | 6.9 | 7.7 |
An instrument that helps evaluate a broad range of psychological problems and symptoms of Borderline Personality Disorder psychopathology. This will be assessed at baseline and visit 8.The 115 items are rated by using a 5-step Likert scale (0=not at all, 4=very strong) and provide a global picture of borderline psychopathology. Global scores of borderline psychopathology are calculated by summing 12 items and range from 0-48. Higher scores indicate more severe symptoms of Borderline Personality Disorder. (NCT03418675)
Timeframe: Baseline, Visit 8 (Week 12)
Intervention | score on a scale (Mean) | |
---|---|---|
Visit 1 | Visit 8 | |
Placebo | 26.17 | 20.25 |
Rexulti | 25.42 | 14.21 |
A clinician-administered scale assessing Borderline Personality Scale severity at all study visits. Scores range from 0-36. Higher scores represent worse Borderline Personality Disorder severity, and lower scores represent milder Borderline Personality Disorder severity. (NCT03418675)
Timeframe: Baseline (Visit 1), Week 1 (Visit 2), Week 2 (Visit 3), Week 4 (Visit 4), Week 6 (Visit 5), Week 8 (Visit 6), Week 10 (Visit 7), Week 12 (Visit 8)
Intervention | score on a scale (Mean) | |||||||
---|---|---|---|---|---|---|---|---|
Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | Visit 6 | Visit 7 | Visit 8 | |
Placebo | 14.9 | 7.6 | 4.7 | 6 | 4.2 | 5.7 | 5 | 8.4 |
Rexulti | 14.9 | 6.7 | 5.3 | 4.4 | 4.5 | 4.9 | 4 | 3.1 |
16 reviews available for hydroxyindoleacetic acid and Alcohol Abuse
Article | Year |
---|---|
Alcoholism and suicidal behavior: a clinical overview.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Antidepressive Agents, Tricyclic; Anxiety; Comorbidity; | 2006 |
Objective post-mortem diagnosis of chronic alcohol abuse--a review of studies on new markers.
Topics: Adipose Tissue; Alcoholism; Biomarkers; Bone Marrow; Brain; Esters; Fatty Acids; Forensic Toxicology | 2008 |
Hypothesized neurochemical models for psychiatric syndromes in alcohol and drug dependence.
Topics: Alcoholism; Brain Diseases; Cocaine; Comorbidity; Diagnosis, Dual (Psychiatry); Dopamine; Dopamine A | 1993 |
Impulse control disorders.
Topics: Aggression; Alcoholism; Disruptive, Impulse Control, and Conduct Disorders; Frontal Lobe; Humans; Hy | 1993 |
Serotonin, violent behavior and alcohol.
Topics: Age Factors; Alcoholism; Animals; Biomarkers; Finland; Homovanillic Acid; Humans; Hydroxyindoleaceti | 1994 |
Biochemical markers for the effects of ethanol.
Topics: Alcohol Drinking; Alcoholism; Aldehyde Dehydrogenase; Animals; Biomarkers; Ethanol; Genetic Markers; | 1993 |
Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence.
Topics: Alcoholism; Brain; Circadian Rhythm; Humans; Hydroxyindoleacetic Acid; Impulsive Behavior; Male; Ris | 1995 |
The use of 5-hydroxytryptophol as an alcohol intake marker.
Topics: Alcohol Drinking; Alcoholism; Animals; Biomarkers; Chromatography, High Pressure Liquid; Ethanol; Ga | 1994 |
A nonhuman primate model of excessive alcohol intake. Personality and neurobiological parallels of type I- and type II-like alcoholism.
Topics: Alcoholic Intoxication; Alcoholism; Animals; Arousal; Brain; Disease Models, Animal; Female; Humans; | 1997 |
[Serotonin metabolism in the framework of aggression and violence].
Topics: Aggression; Alcoholism; Brain; Female; Humans; Hydroxyindoleacetic Acid; Impulsive Behavior; Male; S | 1992 |
Biologic correlates of suicidal risk and aggressive behavioral traits.
Topics: Aggression; Alcoholism; Brain; Depressive Disorder; Humans; Hydroxyindoleacetic Acid; Impulsive Beha | 1992 |
Aggression, suicidality, and serotonin.
Topics: Age Factors; Aggression; Alcoholism; Circadian Rhythm; Depressive Disorder; Humans; Hydroxyindoleace | 1992 |
Suicide and psychiatric patients.
Topics: Adult; Affective Disorders, Psychotic; Alcoholism; Blood Platelets; Emergency Services, Psychiatric; | 1985 |
Suicide: a review of new directions in research.
Topics: Adolescent; Adult; Aged; Alcoholism; Black or African American; Black People; Delusions; Depressive | 1986 |
Alcoholism and suicide.
Topics: Adult; Age Factors; Alcoholism; Depressive Disorder; Female; Glucose; Homovanillic Acid; Humans; Hyd | 1986 |
Neurotransmitters and alcoholism: methodological issues.
Topics: Alcoholism; Humans; Hydroxyindoleacetic Acid; Norepinephrine; Serotonin | 1988 |
3 trials available for hydroxyindoleacetic acid and Alcohol Abuse
Article | Year |
---|---|
Effects of clonidine on central and peripheral catecholamine metabolism.
Topics: Aged; Alcoholism; Blood Pressure; Clonidine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Ma | 1984 |
Changes in serotonin metabolism during treatment with the aldehyde dehydrogenase inhibitors disulfiram and cyanamide.
Topics: Adult; Aged; Alcohol Deterrents; Alcoholism; Aldehyde Dehydrogenase; Cyanamide; Disulfiram; Ethanol; | 1995 |
Buspirone treatment of alcoholism: age of onset, and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking.
Topics: Adult; Age of Onset; Alcoholism; Anti-Anxiety Agents; Buspirone; Double-Blind Method; Homovanillic A | 1999 |
104 other studies available for hydroxyindoleacetic acid and Alcohol Abuse
Article | Year |
---|---|
Chronic voluntary ethanol intake hypersensitizes 5-HT(1A) autoreceptors in C57BL/6J mice.
Topics: 5-Hydroxytryptophan; Action Potentials; Alcohol Drinking; Alcoholism; Animals; Behavior, Animal; Bod | 2008 |
Neuro-inflammation induced in the hippocampus of 'binge drinking' rats may be mediated by elevated extracellular glutamate content.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcoholism; Amino Acids; Animals; Biogenic Monoamines; Conditioning, | 2009 |
Platelet monoamine oxidase activity predicts alcohol sensitivity and voluntary alcohol intake in rhesus monkeys.
Topics: Aggression; Alcohol Drinking; Alcoholism; Animals; Behavior, Animal; Ethanol; Female; Hydroxyindolea | 2010 |
Cholesterol and CSF 5-HIAA in attempted suicide.
Topics: Adjustment Disorders; Adolescent; Adult; Age Factors; Aged; Alcoholism; Anxiety Disorders; Bipolar D | 2010 |
Serotonergic function, substance craving, and psychopathology in detoxified alcohol-addicted males undergoing tryptophan depletion.
Topics: Adult; Alcoholism; Amino Acids; Anxiety; Biogenic Monoamines; Humans; Hydroxyindoleacetic Acid; Inac | 2010 |
Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism].
Topics: Adult; Affect; Alcoholism; Carrier Proteins; Case-Control Studies; Corticotropin-Releasing Hormone; | 2002 |
Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence.
Topics: Adolescent; Adult; Alcohol Drinking; Alcoholism; Biomarkers; Clinical Laboratory Techniques; Ethanol | 2002 |
Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
Topics: Adult; Alcoholism; Case-Control Studies; Chi-Square Distribution; Chromatography, High Pressure Liqu | 2003 |
Urinary excretion of 5-HIAA in chronic alcoholism.
Topics: Alcoholism; Humans; Hydroxyindoleacetic Acid; Indoleacetic Acids | 1962 |
[HUMORAL FACTORS IN THE ETIOLOGY OF DEPRESSION FOLLOWING TREATMENT WITH RAUWOLFIA ALKALOIDS AND IN ALCOHOLICS].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Alcoholics; Alcoholism; Alcohols; Antineoplast | 1964 |
CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence.
Topics: Adult; Alcoholism; Biogenic Monoamines; Depression; Female; Homovanillic Acid; Humans; Hydroxyindole | 2007 |
A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index.
Topics: Alcoholism; Body Mass Index; Crime; Dopamine; Finland; Genotype; Homovanillic Acid; Humans; Hydroxyi | 2006 |
Energy substrate metabolism among habitually violent alcoholic offenders having antisocial personality disorder.
Topics: Adult; Alcoholism; Antisocial Personality Disorder; Calorimetry; Carbohydrates; Cholesterol; Diagnos | 2007 |
Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
Topics: Adult; Alcohol Deterrents; Alcoholism; Comorbidity; Cyanamide; Disulfiram; Female; Follow-Up Studies | 2007 |
Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Alcoholism; Anesthesia, Inhalation; Animals; Breed | 2007 |
Occurrence of trace indoles in mammals.
Topics: Acetaldehyde; Alcoholic Intoxication; Alcoholism; Animals; Brain; Carbolines; Formaldehyde; Humans; | 1984 |
Sleep variables, cyclic AMP and biogenic amine metabolites after one day of ethanol ingestion.
Topics: Adult; Alcohol Drinking; Alcoholism; Cyclic AMP; Ethanol; Homovanillic Acid; Humans; Hydroxyindoleac | 1980 |
Monoamine metabolism in rat brain regions following long term alcohol treatment.
Topics: 5-Hydroxytryptophan; Alcohol Drinking; Alcoholism; Animals; Brain; Dihydroxyphenylalanine; Dopamine; | 1980 |
Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.
Topics: 5-Methoxytryptamine; Adult; Aged; Aging; Alcoholism; Brain; Dementia; Dopamine; Homovanillic Acid; H | 1980 |
[Cerebrospinal fluid monamine metabolites and cyclic nucleotides during alcoholic withdrawal syndrome].
Topics: Adult; Alcoholism; Brain; Cyclic AMP; Cyclic GMP; Female; Homovanillic Acid; Humans; Hydroxyindoleac | 1980 |
Monoamine metabolites in cerebrospinal fluid of depressive subgroups.
Topics: Adult; Alcoholism; Bipolar Disorder; Depressive Disorder; Female; Glycols; Homovanillic Acid; Humans | 1980 |
Concentration of serotonin metabolites in the cerebrospinal fluid from alcoholics before and during disulfiram therapy.
Topics: Alcoholism; Disulfiram; Humans; Hydroxyindoleacetic Acid; Hydroxytryptophol; Male; Serotonin | 1980 |
Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence.
Topics: Alcoholism; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kinetics; Phenylacetates; R | 1981 |
Cerebrospinal fluid 5-hydroxyindoleacetic acid as an index of central serotonergic processes.
Topics: Adult; Aged; Alcoholism; Brain; Depressive Disorder; Epilepsy; Female; Humans; Hydroxyindoleacetic A | 1981 |
The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women.
Topics: Adult; Age Factors; Alcoholism; Body Height; Body Weight; Depressive Disorder; Female; Homovanillic | 1981 |
[Measuring monoamine metabolites and tryptophan levels in the cerebrospinal fluid of alcohol-dependent patients].
Topics: Age Factors; Alcoholism; Amines; Body Height; Body Weight; Female; Humans; Hydroxyindoleacetic Acid; | 1981 |
Regional brain levels of monoamines in alcohol-preferring and -nonpreferring lines of rats.
Topics: Alcoholism; Animals; Brain; Disease Models, Animal; Dopamine; Humans; Hydroxyindoleacetic Acid; Male | 1982 |
Suicide.
Topics: Alcoholism; Brain; Female; Humans; Hydroxyindoleacetic Acid; Male; Risk; Serotonin; Suicide; Suicide | 1982 |
Biochemical and psychopathological predictors of suicidality.
Topics: Alcoholism; Brain; Depressive Disorder; Humans; Hydroxyindoleacetic Acid; Monoamine Oxidase; Recepto | 1982 |
Relationship between cerebrospinal fluid amine metabolites, neuroendocrine findings and personality dimensions (Marke-Nyman scale factors) in psychiatric patients.
Topics: Alcoholism; Bipolar Disorder; Depressive Disorder; Dexamethasone; Female; Homovanillic Acid; Humans; | 1983 |
Amine metabolites and neuroendocrine responses related to depression and suicide.
Topics: Alcoholism; Depression; Depressive Disorder; Dexamethasone; Female; Homovanillic Acid; Humans; Hydro | 1983 |
The effect of dexamethasone on cerebrospinal fluid monoamine metabolites and cortisol in psychiatric patients.
Topics: Adult; Aged; Alcoholism; Bipolar Disorder; Depressive Disorder; Dexamethasone; Female; Homovanillic | 1983 |
Cerebrospinal fluid biochemical examinations: do they reflect clinical or biological differences?
Topics: Adult; Aged; Alcoholism; Bipolar Disorder; Calcium; Depressive Disorder; Dexamethasone; Female; Homo | 1983 |
The effect of alcoholism on salsolinol and biogenic amines in human brain.
Topics: Alcoholism; Biogenic Amines; Brain; Caudate Nucleus; Dopamine; Homovanillic Acid; Humans; Hydroxyind | 1983 |
Monoamine and metabolite levels in CNS regions of the P line of alcohol-preferring rats after acute and chronic ethanol treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcoholic Intoxication; Alcoholism; Animals; Brain Chemistry; Choice | 1983 |
The effect of long-term ethanol maternal ingestion and withdrawal on brain regional monoamine and amino acid precursors in 15-day-old rats.
Topics: Alcoholism; Amino Acids; Animals; Biogenic Amines; Brain Chemistry; Catecholamines; Female; Humans; | 1984 |
5-hydroxytryptophol in human cerebrospinal fluid: conjugation, concentration gradient, relationship to 5-hydroxyindoleacetic acid, and influence of hereditary factors.
Topics: Adolescent; Adult; Age Factors; Alcoholism; Depression; Female; Humans; Hydroxyindoleacetic Acid; Hy | 1984 |
Mapping of the serotonin 5-HT1D beta autoreceptor gene on chromosome 6 and direct analysis for sequence variants.
Topics: Alcoholism; Base Sequence; Brain; Chromosome Mapping; Chromosomes, Human, Pair 6; DNA Primers; Genet | 1995 |
Personality profiles and state aggressiveness in Finnish alcoholic, violent offenders, fire setters, and healthy volunteers.
Topics: Adult; Age of Onset; Aggression; Alcoholism; Aspartame; Finland; Firesetting Behavior; Forensic Psyc | 1994 |
CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers.
Topics: Adrenocorticotropic Hormone; Adult; Alcoholism; Antisocial Personality Disorder; Circadian Rhythm; D | 1994 |
Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism.
Topics: Adult; Alcoholism; Antisocial Personality Disorder; Disruptive, Impulse Control, and Conduct Disorde | 1994 |
Simultaneous analysis of homovanillic acid, 5-hydroxyindoleacetic acid, 3-methoxy-4-hydroxyphenylethylene glycol and vanilmandelic acid in plasma from alcoholics by high-performance liquid chromatography with electrochemical detection. Critical comparison
Topics: Alcohol Withdrawal Delirium; Alcoholism; Biogenic Monoamines; Chromatography, High Pressure Liquid; | 1993 |
Circadian variations in plasma monoamine metabolites level in alcoholic patients: a possible predictor of alcohol withdrawal delirium.
Topics: Adult; Alcohol Withdrawal Delirium; Alcoholism; Analysis of Variance; Biogenic Monoamines; Circadian | 1994 |
Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies.
Topics: Adrenocorticotropic Hormone; Adult; Alcoholism; Corticotropin-Releasing Hormone; Humans; Hydrocortis | 1994 |
The urinary excretion of tryptophan and tryptophan metabolites in the chronic ethanol-fed rat.
Topics: Alcoholism; Animals; Chromatography, High Pressure Liquid; Diet; Ethanol; Hydroxyindoleacetic Acid; | 1993 |
Circadian variation in plasma 5-hydroxyindoleacetic acid level during and after alcohol withdrawal: phase advances in alcoholic patients compared with normal subjects.
Topics: Adult; Alcohol Withdrawal Delirium; Alcoholism; Circadian Rhythm; Humans; Hydroxyindoleacetic Acid; | 1993 |
Detection of relapses in alcohol-dependent patients: comparison of carbohydrate-deficient transferrin in serum, 5-hydroxytryptophol in urine, and self-reports.
Topics: Adult; Alcoholism; Biomarkers; Creatinine; Humans; Hydroxyindoleacetic Acid; Hydroxytryptophol; Male | 1993 |
Laboratory testing for recent alcohol consumption: comparison of ethanol, methanol, and 5-hydroxytryptophol.
Topics: Adult; Alcohol Drinking; Alcoholism; Breath Tests; Ethanol; Female; Humans; Hydroxyindoleacetic Acid | 1996 |
Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics.
Topics: Adult; Age of Onset; Alcohol Drinking; Alcoholism; Comorbidity; Family; Female; Homovanillic Acid; H | 1996 |
A prospective follow-up study of alcoholic violent offenders and fire setters.
Topics: Adult; Alcoholism; Cholesterol; Comorbidity; Criminal Law; Family; Finland; Firesetting Behavior; Fo | 1996 |
A nonhuman primate model of type II excessive alcohol consumption? Part 1. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations and diminished social competence correlate with excessive alcohol consumption.
Topics: Adult; Affect; Age Factors; Alcohol Drinking; Alcoholism; Animals; Arousal; Disease Models, Animal; | 1996 |
A nonhuman primate model of type II alcoholism? Part 2. Diminished social competence and excessive aggression correlates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations.
Topics: Adult; Age Factors; Aggression; Alcohol Drinking; Alcoholism; Animals; Antisocial Personality Disord | 1996 |
Sub-populations of alcohol-dependent patients: differences in psychological functioning between high- and low-frequency alcohol consumers.
Topics: Adaptation, Psychological; Adult; Alcoholism; Depression; Humans; Hydroxyindoleacetic Acid; Hydroxyt | 1996 |
Prevalence of high serotonin uptake in lymphocytes of abstinent alcoholics.
Topics: Adult; Alcoholics Anonymous; Alcoholism; Carrier Proteins; Female; Humans; Hydroxyindoleacetic Acid; | 1997 |
Monitoring relapse drinking during disulfiram therapy by assay of urinary 5-hydroxytryptophol.
Topics: Adult; Alcohol Deterrents; Alcoholism; Ambulatory Care; Disulfiram; Dose-Response Relationship, Drug | 1998 |
In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in nonhuman primates.
Topics: Adult; Aggression; Alcoholic Intoxication; Alcoholism; Animals; Behavior, Animal; Brain; Brain Stem; | 1998 |
Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics.
Topics: Adult; Age of Onset; Alcoholism; Biomarkers; Case-Control Studies; Cholesterol; Cross-Sectional Stud | 1998 |
Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics.
Topics: Adult; Age of Onset; Alcoholism; Biomarkers; Case-Control Studies; Cholesterol; Cross-Sectional Stud | 1998 |
Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics.
Topics: Adult; Age of Onset; Alcoholism; Biomarkers; Case-Control Studies; Cholesterol; Cross-Sectional Stud | 1998 |
Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics.
Topics: Adult; Age of Onset; Alcoholism; Biomarkers; Case-Control Studies; Cholesterol; Cross-Sectional Stud | 1998 |
The urinary ratio of 5-hydroxytryptophol to 5-hydroxyindole-3-acetic acid in surgical patients with chronic alcohol misuse.
Topics: Adult; Aged; Alcoholism; Biomarkers; Digestive System Neoplasms; Erythrocyte Indices; Ethanol; Human | 1999 |
Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers.
Topics: Adult; Alcoholism; Amino Acids; Brain; Brain Chemistry; Diet; Female; Humans; Hydroxyindoleacetic Ac | 1999 |
Technique for producing an alcohol withdrawal syndrome in rats.
Topics: Alcoholism; Animals; Behavior, Animal; Brain; Butanols; Disease Models, Animal; Ethanol; Heart Rate; | 1973 |
CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?
Topics: Adult; Alcoholism; Behavior, Addictive; Biogenic Monoamines; Biomarkers; Case-Control Studies; Ethan | 1999 |
HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses.
Topics: Alcoholism; Biogenic Monoamines; Brain; Dopamine; Genes; Genotype; Homovanillic Acid; Humans; Hydrox | 1999 |
Serotonin, testosterone and alcohol in the etiology of domestic violence.
Topics: Adult; Aggression; Alcoholism; Conditioning, Classical; Fear; Humans; Hydroxyindoleacetic Acid; Male | 2001 |
Neurochemical correlates of ethanol withdrawal: alterations in serotoninergic function.
Topics: Alcoholism; Animals; Brain Chemistry; Brain Stem; Humans; Hydroxyindoleacetic Acid; Male; Mice; Mice | 1977 |
Alcohol, sleep and cerebrospinal fluid changes in alcoholics: cyclic AMP and biogenic amine metabolites in CSF.
Topics: Adult; Alcoholism; Biogenic Amines; Cyclic AMP; Ethanol; Homovanillic Acid; Humans; Hydroxyindoleace | 1977 |
Changes in the metabolism of biogenic amines in alcoholism--especially regarding CSF monoamine metabolites and serum DBH activity.
Topics: Adult; Aged; Alcoholism; Biogenic Amines; Dopamine beta-Hydroxylase; Female; Homovanillic Acid; Huma | 1979 |
Naloxone (Narcan) treatment in depression: clinical observations and effects on CSF endorphins and monoamine metabolites.
Topics: Adult; Alcoholism; Biogenic Amines; Depression; Endorphins; Female; Homovanillic Acid; Humans; Hydro | 1977 |
Alcohol and central serotonin metabolism in man.
Topics: Adult; Alcoholism; Brain; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middl | 1979 |
Measures of physical dependence and involvement of serotonin in withdrawal symptomatology.
Topics: Alcoholism; Animals; Body Temperature; Brain Chemistry; Humans; Hydroxyindoleacetic Acid; Mice; Mice | 1977 |
Urinary metabolites of tryptophan, serotonin and norepinephrine in alcoholics.
Topics: Adult; Alcoholism; Female; Humans; Hydroxyindoleacetic Acid; Liver Diseases; Liver Function Tests; M | 1978 |
Differential changes of blood and urinary indoleamines following intravenous ethanol administration in alcoholic and non-drinker women.
Topics: Adult; Alcoholism; Ethanol; Female; Humans; Hydroxyindoleacetic Acid; Hydroxytryptophol; Indoles; Mi | 1978 |
[Variations of CSF levels of 5-HIAA in chronic alcoholism].
Topics: Adult; Alcoholism; Brain; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Serotonin | 1976 |
D2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid and 3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States.
Topics: Adult; Alcoholism; Alleles; Ethnicity; Finland; Genotype; Homovanillic Acid; Humans; Hydroxyindoleac | 1992 |
Psychobiology of violent behavior.
Topics: Alcoholism; Behavior; Humans; Hydroxyindoleacetic Acid; Impulsive Behavior; Models, Psychological; V | 1992 |
Ethanol enhances the release of dopamine and serotonin in the nucleus accumbens of HAD and LAD lines of rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcoholism; Animals; Dopamine; Dose-Response Relationship, Drug; Eth | 1992 |
Biological markers of alcoholism.
Topics: Adenylyl Cyclases; Alcoholism; Aldehyde Dehydrogenase; Biomarkers; Blood Volume; Humans; Hydroxyindo | 1992 |
Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide.
Topics: Adult; Alcoholism; Biogenic Monoamines; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxy | 1990 |
Clinical characteristics of female alcoholics with low platelet monoamine oxidase activity.
Topics: Adult; Alcoholism; Blood Platelets; Female; Humans; Hydroxyindoleacetic Acid; Middle Aged; Monoamine | 1990 |
A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism.
Topics: Adult; Alcoholism; Anxiety Disorders; beta-Endorphin; Diazepam Binding Inhibitor; Fear; Homovanillic | 1990 |
Cerebrospinal fluid thyrotropin-releasing hormone concentrations in alcoholics and normal controls.
Topics: Adult; Alcoholism; Depressive Disorder; Female; Humans; Hydroxyindoleacetic Acid; Hypothalamo-Hypoph | 1990 |
Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aggression; Alcoholism; Homovanillic Acid; Humans; Hydroxyind | 1991 |
Temporal studies of the inhibition of voluntary ethanol intake in the rat induced by intermittent ethanol treatment and some long term neurochemical consequences.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Alcoholism; Animals; Brain; Brain Mapping; Dopamin | 1991 |
[Hormonal changes and biologically active substances in alcoholic women in the reproductive age].
Topics: Acetylcholine; Adolescent; Adult; Age Factors; Alcoholism; Aldosterone; Female; Gonadal Steroid Horm | 1991 |
Cerebrospinal fluid variables among alcoholics lack seasonal variation.
Topics: Adult; Alcoholism; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxy | 1991 |
Serotonin and dopamine systems regulating alcohol intake.
Topics: Alcohol Drinking; Alcoholism; Animals; Dopamine; Ethanol; Frontal Lobe; Hydroxyindoleacetic Acid; Li | 1991 |
Dementias, psychological tests, and neurotransmitters.
Topics: Aged; Alcoholism; Alzheimer Disease; Dementia; Diagnosis, Differential; Female; Homovanillic Acid; H | 1985 |
Indices of serotonin and glucose metabolism in violent offenders, arsonists, and alcoholics.
Topics: Alcoholism; Antisocial Personality Disorder; Blood Glucose; Disruptive, Impulse Control, and Conduct | 1986 |
Biochemical aspects of aggression in man.
Topics: Aggression; Alcoholism; Biochemical Phenomena; Biochemistry; Humans; Hydroxyindoleacetic Acid; Impul | 1986 |
Contents of monoamines in forebrain regions of alcohol-preferring (P) and -nonpreferring (NP) lines of rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Alcoholism; Animals; Biogenic Amines; Brain; Cereb | 1987 |
Reduced central serotonin turnover in a subgroup of alcoholics?
Topics: Aggression; Alcoholism; Blood Glucose; Brain; Firesetting Behavior; Humans; Hydroxyindoleacetic Acid | 1987 |
Serotonergic activity and disinhibitory psychopathy in alcoholism.
Topics: Aggression; Alcoholism; Attention Deficit Disorder with Hyperactivity; Brain; Humans; Hydroxyindolea | 1987 |
Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters. A follow-up study.
Topics: Adult; Alcoholism; Blood Glucose; Criminal Psychology; Depressive Disorder; Disruptive, Impulse Cont | 1989 |
Family history of alcoholism in violent offenders and impulsive fire setters.
Topics: Adult; Alcoholism; Criminal Psychology; Disruptive, Impulse Control, and Conduct Disorders; Fathers; | 1989 |
CSF studies on alcoholism and related behaviours.
Topics: Alcoholism; Antisocial Personality Disorder; Gambling; Humans; Hydroxyindoleacetic Acid; Personality | 1989 |
Liver tryptophan pyrrolase. A major determinant of the lower brain 5-hydroxytryptamine concentration in alcohol-preferring C57BL mice.
Topics: Alcoholism; Animals; Brain; Disease Models, Animal; Homeostasis; Hydroxyindoleacetic Acid; Liver; Ma | 1989 |
Homicide, suicide and CSF 5-HIAA.
Topics: Adult; Aggression; Alcoholism; Homicide; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; | 1985 |
Alcohol addiction: a biochemical approach.
Topics: Acetaldehyde; Alcoholism; Alkaloids; Amines; Biogenic Amines; Ethanol; Humans; Hydroxyindoleacetic A | 1972 |
5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.
Topics: Alcoholism; Bipolar Disorder; Central Nervous System Diseases; Humans; Hydroxyindoleacetic Acid; Imi | 1966 |
Renal function, renin activity and endogenous vasoactive substances in cirrhosis.
Topics: Alcoholism; Angiotensin II; Ascites; Catecholamines; Dopamine; Glomerular Filtration Rate; Humans; H | 1970 |
CSF monoamine metabolites in alcoholism: a comparative study with depression.
Topics: Adult; Aged; Alcoholism; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Ma | 1974 |
Regional distribution of brain 5-hydroxytryptamine in rat strains selected for their alcohol intake.
Topics: Alcohol Drinking; Alcoholism; Animals; Brain; Brain Chemistry; Disease Models, Animal; Ethanol; Huma | 1973 |
5-Hydroxytryptamine and 5-hydroxyindolylacetic acid content in brain of rat strains selected for their alcohol intake.
Topics: Alcohol Drinking; Alcoholism; Animals; Body Temperature; Brain; Brain Chemistry; Disease Models, Ani | 1972 |
Relationship of dietary tryptophan and niacin to tryptophan metabolism in alcoholics and nonalcoholics.
Topics: Acetates; Alcoholism; Aminohippuric Acids; Diet; Dietary Proteins; Female; Humans; Hydroxyindoleacet | 1974 |
[The relationship of the metabolism of biogenic amines to affective pathology in chronic alcoholism].
Topics: Affective Symptoms; Alcoholism; Catecholamines; Chronic Disease; Dihydroxyphenylalanine; Dopamine; E | 1969 |